The virtual health market for weight loss has exploded. Dozens of platforms now offer GLP-1 prescriptions online, and the differences between them — pricing, physician quality, follow-up care, medication options — are substantial. We reviewed the major platforms head-to-head to help you find the right fit.
What Makes a Good Virtual Weight Loss Platform
Before comparing specific providers, it helps to know what separates good from mediocre. The core criteria are clinical rigor (licensed prescribers, proper intake screening, contraindication checks), medication access (both compounded and brand-name options), pricing transparency (no hidden fees, clear refill costs), follow-up care (dose titration guidance, side effect management, check-ins), and accessibility (state coverage, shipping speed, support responsiveness).
Every platform we review is US-licensed and uses licensed prescribers and pharmacies. The differences are in how well they execute across these five dimensions.
The 2026 Landscape: What's Changed
Three major shifts reshaped virtual weight loss in 2025–2026. First, Eli Lilly launched LillyDirect, selling brand-name Zepbound directly to consumers at $399/month — bypassing insurance and telehealth middlemen. Second, the FDA's compounding guidance evolved after the semaglutide shortage ended, creating regulatory uncertainty for some compounding pharmacies. Third, clinical outcome data matured: the SELECT trial proved cardiovascular benefit, and real-world data from millions of telehealth patients clarified which platforms produce sustained results versus quick prescriptions with high dropout.
Key Stat
GLP-1 medications produce 15–22% body weight reduction in clinical trials — far exceeding any prior pharmacological intervention. The critical variable isn't the medication. It's the clinical support surrounding it: dose titration, dietary guidance, and long-term follow-up.
Platform Categories
High-Touch Clinical Platforms ($250–400/mo)
These platforms pair GLP-1 prescriptions with structured clinical support — dietitian consultations, regular video check-ins, body composition tracking, and physician-managed dose titration. Monthly costs are higher, but retention and clinical outcomes tend to be significantly better. Patients who stay on structured programs for 6+ months typically lose more weight and maintain it longer than those on prescription-only platforms.
Mid-Range Prescription Platforms ($150–250/mo)
The sweet spot for most patients. These platforms provide legitimate prescribing with basic follow-up support — messaging with your care team, dose adjustment consultations, and refill management. They balance clinical quality with affordability and represent the largest segment of the market.
Brand-Name Access Platforms ($175–400/mo)
For patients who want FDA-approved brand-name medications (Wegovy, Zepbound) rather than compounded versions. Pricing is higher, but you're getting the exact formulation used in clinical trials with standardized manufacturing. Insurance may cover part or all of the cost if prior authorization is approved.
Watch for: Platforms advertising extremely low prices ($49/mo, $79/mo) for GLP-1 medications. These often use aggressive titration schedules, minimal physician oversight, and may not include the actual medication cost in the advertised price. If a deal looks too good to be true, ask what's included before entering payment information.
Top-Reviewed Virtual Weight Loss Platforms
All providers below are US-licensed telehealth platforms. Availability varies by state.
⚕️ Compounded medications are not FDA-approved. They are prepared by licensed pharmacies under physician supervision.
⚕️ Compounded medications are not FDA-approved. They are prepared by licensed pharmacies under physician supervision.
⚕️ Compounded medications are not FDA-approved. They are prepared by licensed pharmacies under physician supervision.
How to Choose
Start with your budget and medication preference. If you want brand-name medications and have insurance, explore whether your plan covers GLP-1s before going the telehealth route. If you're paying out of pocket and want the best value, compounded medication through a mid-range platform typically delivers the best cost-to-outcome ratio. If you want maximum clinical support and can afford $300+/month, high-touch platforms with integrated coaching produce the strongest sustained results.
Regardless of which platform you choose, the most important factor is follow-up care. A prescription without ongoing clinical management is a prescription with a high dropout rate. Ask specifically about what happens after your first month — how dose adjustments work, whether you have access to a provider for side-effect questions, and what the cancellation process looks like.
Sources & References
- Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)." NEJM. 2021;384:989–1002.
- Lincoff AM, et al. "Semaglutide and Cardiovascular Outcomes (SELECT Trial)." NEJM. 2023;389:2221–2232.
- Eli Lilly. LillyDirect Zepbound Program. 2025–2026.
- FDA. Compounding Quality Act and GLP-1 Guidance. 2025 updates.
- Obesity Medicine Association. Telehealth Best Practices for Obesity Management. 2025.